The introduction of GnRH antagonists (GnRH-ant) to suppress the LH surge in IVF cycles and the GnRH agonist (GnRH-a) triggering followed by a “freeze all” policy have dramatically reduced if not eliminated the risk of OHSS [17]. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.